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Pregnancy in women with reflux nephropathy. Reflux nephropathy is
one of the most prevalent renal diseases and a leading cause of chronic
renal failure in women of childbearing age. To evaluate the issue and
possible complications of pregnancy in women with reflux nephropathy,
we retrospectively analyzed fetal and maternal outcome in 158 women
who had 375 pregnancies between 1965 and 1994. The overall fetal death
rate was 10.2% and tended to decrease in the 1985 to 1994 decade as
compared to the preceding period (8.4% vs. 12.6%). The relative risk of
fetal death was 4.8 times greater when hypertension was present at
conception than in normotensive patients. Fetal death rate was also higher
in patients with impaired renal function that in those with serum creati-
nine < 0.11 mmol/liter at conception (36.7% vs. 7.7%, P < 0.0001).
Urinaiy tract infection accounted for frequent morbidity but seldom
resulted in fetal mortality. Maternal renal disease was unaffected by
pregnancy, excepted for 4 of the 21 patients with pre-existing renal failure
who exhibited an irreversibly accelerated course after pregnancy. We
conclude that pregnancy is essentially successful and uneventful in patients
diagnosed with reflux nephropathy who have normal blood pressure and
preserved renal function, whereas the fetal prognosis is more compro-
mised and there is a risk of accelerated progression of maternal renal
disease when serum creatinine concentration is in excess of 0.22 mmol/
liter. This suggests that women with reflux nephropathy should preferably
conceive before having reached that stage of renal failure.
Reflux nephropathy is one of the most common renal diseases
encountered in women of childbearing age, and constitutes a
leading cause of chronic renal failure in women in the third and
fourth decades of life [1—6]. As a consequence, problems associ-
ated with pregnancy are of important concern because reflux
nephropathy may be complicated by urinary tract infection,
hypertension and/or impairment of renal function [7, 8], all of
which may affect the outcome of pregnancy. Surprisingly, very few
studies have been specifically devoted to the interrelations be-
tween reflux nephropathy and pregnancy with exception for
reports of El Khatib et al [9] and of our own group [10—12].
Our updated experience now bears on 158 women with refiux
nephropathy who had a total number of 375 pregnancies during
the past three decades. Based on this large cohort, we analyzed
the reciprocal influence of reflux nephropathy on fetal outcome,
and of pregnancy on the course of maternal renal disease, to
identify factors of fetal and maternal prognosis, particularly in
patients whose renal function was impaired at conception. By
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comparing outcome of pregnancies in the past decade and in the
preceding period, we were able to evaluate the effect of current
progress in obstetrics and neonatology as well as of the policy of
more active treatment of hypertension we adopted in the recent
years on the basis of our previous experience [10].
Methods
Patients
We reviewed the charts of all 189 women with reflux nephrop-
athy referred to our institution between 1965 and 1994, of whom
158 were pregnant at least once and constitute the study popula-
tion, the other 31 who did not conceive serving as a control group.
Reflux nephropathy was defined by the presence, in one or both
kidneys, of characteristic renal scars on intravenous urography
whether vesicoureteral reflux was present or not at presentation
[13, 14]. Vesicoureteral reflux was defined by the evidence of
reflux of contrast medium from bladder to one or both ureters
during micturating cystography [15].
Obstetrical history was evaluated in most cases from the data
included in patient records. First-trimester spontaneous, but not
therapeutic abortions were taken into account in the evaluation of
fetal outcome. Full-term delivery was defined as occurring after 37
weeks of gestation or more. Preterm delivery was defined as
occurring between the 27th and 36th gestational weeks. Termina-
tion of pregnancy prior to 20 weeks of gestation was designated an
abortion. Fetal death between the 20th and 26th gestational weeks
was designated an intrauterine fetal death, and stillbirth the death
of a viable fetus, that is, after the 26th week of gestation. Perinatal
mortality was the sum of stillbirths and neonatal deaths.
For each gestation we recorded the level of maternal blood
pressure, serum creatinine (Sr), hemoglobin and 24-hour urinary
protein excretion prior to conception, during pregnancy, post
partum (2 to 4 months of delivery) and in the subsequent
follow-up (median duration 12 years; range ito 28 years after last
pregnancy). Upper and lower urinary tract infection (UT!) epi-
sodes occurring during pregnancy were recorded, as well as past
history of UTI and of surgical correction of vesicoureteral reflux.
Upper UTI was defined as the ocurrence of pyuria with lumbar
pain and fever. Lower UT! was defined by isolated bacteriuria.
Hypertension was defined by blood pressure  140/90 mm Hg or
mean arterial pressure (MAP) > 105 mm Hg, at any time before
or during pregnancy. Preeclampsia was defined as the develop-
ment of hypertension after the 20th week of gestation together
with onset (or increase) of proteinuria in previously normotensive
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patients, and superimposed preeclampsia by a concomitant in-
crease in proteinuria (by more than 50%) and in blood pressure
level (by at least 30 mm Hg of systolic blood pressure) in patients
with previous hypertension and/or proteinuria.
Statistical methods
Data are presented as means SD. Intergroup comparisons
were performed using the test, the Fisher's exact test and the
Mann-Whitney test or the Wilcoxon test for unpaired or paired
values, respectively. Logistic regression analysis was used to assess
the influence of predictive factors on pregnancy outcome.
Results
Status of patients at conception
As a whole, 158 women had 375 pregnancies (377 fetuses), a
mean of 2.37 per patient. Their median age at onset of first
pregnancy was 23 years (range 16 to 32). Twenty-one patients
underwent surgical correction of vesicoureteral reflux before
becoming pregnant, including 16 who were operated in infancy
and 5 in whom correction was performed at the adult age because
of recurrent pyelonephritic episodes after onset of sexual activity.
Voiding cystography was performed at the adult age in 113
patients and evidenced persistence of uni- or bilateral vesi-
coureteral reflux in 49 patients (43%) whereas no reflux was
apparent in 64 patients, including the above-mentioned 16 who
underwent surgical repair in infancy, thus indicating spontaneous
resolution in the other 54 patients.
Diagnosis of reflux nephropathy was known prior to the first
pregnancy in 44% of patients, UTI being the revealing feature in
84% of cases. Reflux nephropathy revealed during the first
pregnancy in 32% of the patients, revealing features being UT! in
57% of cases, hypertension in 26%, proteinuria in 14% and renal
failure in 3%. In 24% of patients, diagnosis of reflux nephropathy
was established later, mainly due to an obstetrical complication
during a subsequent gestation. Hypertension was present at
conception in 34 pregnancies, either isolated (10 cases) or con-
comitant to impaired renal function (24 cases). Renal failure
defined by a Sr level > 0.11 mmol/liter was present at conception
in 30 pregnancies (in 21 patients) with a mean preconception Sr
value of 184 77 .tmol/1iter (range 112 to 490). Among these, 24
pregnancies (in 16 patients) were prospectively managed in close
cooperation with obstetrical units of University hospitals having
experience in the care of high-risk pregnancies.
Maternal complications during pregnancy
UTI was the most common complication which occurred in 84
pregnancies (22.3%) in 65 patients (Table 1). UTI was limited to
lower urinary tract in 49 pregnancies (in 34 patients) whereas
acute pyelonephritis occurred in 35 pregnancies in 31 patients of
whom 21 (68%) had experienced previous pyelonephritic epi-
sodes. Of the upper UTI episodes, 20 (41%) occurred in the 49
patients having documented persistent vesicoureteral reflux at the
adult age, whereas only 12 (19%, P < 0.01) were observed in the
64 patients with spontaneous resolution of the vesicoureteral
reflux and 3 (14%) in the 21 patients who underwent previous
surgical correction of vesicoureteral reflux (P < 0.01, when
compared with the group with persistent vesicoureteral reflux).
Hypertension complicated the course of 54 pregnancies
(14.3%). In 34 cases where it was present at conception (concom-
Table 1. Complications associated with pregnancy in 158 women with
reflux nephropathy according to serum creatinine (Sr) level at
conception
Whole series
Scr (mmol/liter)
0.11 > 0.11 P value
Number of patients 158 137 21
Pregnancies (fetuses) 375 (377) 345 (346) 30 (31)
Urinary tract infection
lower UTI alone 49 (13%) 46 (13.3%) 3 (10%) NS
upper UTI 35 (9.3%) 33 (9.6%) 2 (6.7%) NS
Hypertension
early in pregnancy 34 (9.1%) 10 (2.9%) 24 (80%) <0.0001
late in pregnancy 20 (5.3%) 18 (5.2%) 2 (6.7%) NS
Preeclampsia 39 (10.4%) 22 (6.4%) 17 (57%) <0.0001
Increase in Scr in
pregnancy
reversible 30 (8%) 4 (1.2%) 26 (87%) <0.0001
irreversible 4 (1.1%) 0 4 (13.4%) < 0.0001
itant with impaired renal function in 24 cases), hypertension
exacerbated during pregnancy thus requiring institution or rein-
forcement of antihypertensive therapy (by methyl dopa and/or
beta blockers in all cases), and was complicated by superimposed
preeclampsia in 23 cases (68%). In 20 cases hypertension devel-
oped only in the third trimester of pregnancy; preeclampsia
occurred in 16 cases (75%) in this situation. As a whole, pre-
eclampsia complicated the course of 39 pregnancies (10.4%)
including 16 cases (13%) among 127 normotensive primiparas
with preserved renal function. Preeclampsia was significantly
more frequent in women having impaired renal function at
conception (17 of 30 cases, or 56.7%) than in those with Sr <
0.11 mmol/liter (22 of 345 pregnancies, or 6.4%, P < 0.0001).
Deterioration of renal function was not observed during preg-
nancy in patients having preserved renal function at conception,
with exception for four cases of moderate, reversible Sr rise in
late gestation. By contrast, an increase in Sr was observed by the
end of gestation in all patients whose renal function was impaired
at conception, but in no case dialysis had to be started during
pregnancy.
Fetal outcome
Of the 375 pregnancies (with 377 fetuses, including 2 twin
pregnancies), 254 ended in full-term delivery of 255 living babies,
and 77 in preterm delivery with 63 living babies (including a set of
twins) and 14 stillbirths. There were 22 spontaneous abortions
(including 2 ectopic pregnancies, 12 first-trimester abortions, and
8 late abortions between the 12th and 20th gestational week) and
23 therapeutic abortions. Total fetal loss in the whole series was
59 of 377 fetuses (15.6%), but corrected fetal loss, not considering
induced abortions, was 36 of 354 fetuses (10.2%). A total of 316
pregnancies (318 fetuses), or 89.8%, resulted in live births. The
mean birthweight of living neonates known in 271 cases was 3050
580 g (range 960 to 4250).
Compared fetal outcome in pregnancies that took place before
1985 (period I) and from 1985 to 1994 (period II) is summarized
in Table 2. Fetal death rate was lower in the recent decade than
in the preceding period (8.4% vs. 12.6%), although the difference
did not reach statistical significance. This was observed despite the
higher proportion of preterm deliveries (29% vs. 17.4%, P <
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Table 2. Compared fetal outcome of 375 pregnancies (377 fetuses) in
period I and in period II
Whole
series
Period I
(1965—1984)
Period II
(1985—1994) P value
Patients 158 67 91
Pregnancies (fetuses) 375 (377) 162 (162) 213 (215)
Induced abortion 23 (6.1%) 11(6.8%) 12 (5.6%) MS
Spontaneous abortions 22 (6.2%) 10 (6.6%) 12 (5.9%) MS
Stillbirths 14 (4%) 9 (6%) 5 (2.5%) 0.09
Corrected fetal deatha 36/354
(10.2%)
19/151
(12.6%)
17/203
(8.4%) 0.19
Live birthsa 318 (89.8%) 132 (87.4%) 186 (91.6%) 0.19
Preterm delivered 77 (24.2%) 23 (17.4%) 54 (29%)** 0.017
Birthweight g 3050 580 3130 720 2980 640 NS
N 271 112 159
a Not considering induced abortionsb Including a set of twins
0.02), thus reflecting a lower perinatal mortality rate in prema-
turely delivered infants in the recent decade (5 of 59 fetuses, or
8.5% vs. 9 of 32 fetuses, or 28%; P < 0.03).
The respective influence of UT!, hypertension and renal failure
on fetal outcome was analyzed in the whole series. Only three out
of the 36 spontaneous fetal deaths (8.3%) could be attributed to
UTI (including 1 case with recurrent lower UT! and 2 cases with
acute pyelonephritis) in the absence of other risk factors such as
renal failure or hypertension. The role of UT! was more disput-
able in three other instances because other risk factors coexisted.
In a poorly compliant patient with persistent vesicoureteral reflux,
recurrent lower UT! episodes occurred during two successive
gestations, in addition to hypertension and impaired renal func-
tion (Scr 133 and 168 xmo1/liter, respectively) and both ended in
intrauterine fetal death. In another patient with hypertension and
SCr 140 xmo!/liter at conception, a severe acute pyelonephritic
episode at the 26th gestational week was followed two weeks later
by preeclampsia and abruptio placentae ending in stillbirth.
The deleterious influence of hypertension and of renal failure
was much more apparent. Among the 34 pregnancies where
hypertension was present prior to conception, 13 (38.2%) ended
in fetal death, including one therapeutic abortion, two spontane-
ous abortions and 10 intrauterine fetal deaths or stillbirths. In this
subset, live births were significantly more frequent in patients
whose blood pressure was well controlled by antihypertensive
therapy (17 of 19, or 89.5%) than in those with poorly controlled
blood pressure (4 of 15, or 26.7%; P < 0.0001), but the birth-
weight was below 2500 g in 13 cases (including twins). No fetal
death occurred in 20 pregnancies where hypertension developed
late in pregnancy, even in the context of preeclampsia. As a whole,
not considering therapeutic abortions, fetal death rate was signif-
icantly lower in patients with normal blood pressure at conception
than in pregnancies complicated by early hypertension (24 of 321
fetuses, or 7.5% vs. 12 of 33, or 36.4%; P < 0.01), the relative risk
of fetal loss being 4.8 times higher in hypertensive than in
normotensive patients.
Only 19 (63.3%) of 30 pregnancies (31 fetuses) started in
patients whose Sr was > 0.11 mmol/liter at conception (hyper-
tension was concomitant in 24 cases) ended in live birth, whereas
pregnancy was successful in 299 (92.3%) of 324 pregnancies (not
considering induced abortions) started with Sr< 0.11 mmol/liter
at conception, a highly significant difference (P < 0.0001; Table
3). Mean birthweight of living neonates was significantly lower in
Table 3. Fetal outcome according to renal function at start of
pregnancy
5Cr before pregnancy
0.11 > 0.11
mmol/liter mmol/liter P value
Patients 137 21
Pregnancies (fetuses) 345 (346) 30 (31)
Induced abortions 22 (6.4%) 1 (3.2%) NS
Spontaneous abortions 19 (5.9%) 3 (10%) NS
Stillbirths 6 (1.9%) 8 (26.7%) < 0.0001
Corrected fetal deatha 25/324
(7.7%)
11/30
(36.7%)
< 0.0001
Live births 299/324
(92.3%y
19/30
(63.3%y
< 0.0001
Preterm delivery 62/299
(21%)
15/19
(79%)
< 0.0001
Birthweight g 3120 530 2310 510 < 0.0001N 251 19
a Not considering induced abortions
patients with Sr > 0.11 mmol/liter than in those with normal
renal function, but there was no significant relationship between
the S value at conception and the living neonate's birthweight
(r = —0.18, NS).
To evaluate the impact of prospective coordinated care on fetal
prognosis, we retrospectively compared fetal outcome in pregnan-
cies who benefited such coordinated management and in those
who did not. Among patients with impaired renal function, fetal
outcome was significantly more favorable in 24 planned pregnan-
cies when they had coordinated nephrological and obstetrical care
than in the 6 pregnancies (most occurred in period I) in whom
renal disease was diagnosed because of an obstetrical complica-
tion and therefore did not benefit such prospective management.
In the latter situation, no gestation was successful; there were four
stillbirths and two first-trimester abortions (including one thera-
peutic).
By contrast, in patients with prospective coordinated care
(Table 4), 18 (75%) of 24 pregnancies ended in live birth
(including a twin gestation), a significantly higher success rate
(P < 0.0001), but the incidence of preterm delivery was very high
(12 of 18, or 62%), and birthweight of 14 of the 19 living neonates
(including twins, whose birthweight was 980 and 960 g) was under
2500 g (range 960 to 2450 g). Fetal loss rate was higher in
pregnancies where preconception SCr level ranged from 0.20 to
0.49 mmol/liter than in those started with a Sr level < 0.20
mmol/Iiter (3 of 7 or 43%, vs. 3 of 19 fetuses, or 16%), but the
difference did not reach statistical significance. Two spontaneous
first-trimester abortions occurred in hypertensive patients with
Se,, respectively 0.49 and 0.33 mmol/liter at conception, and a
pregnancy started with a Sr of 0.27 mmol/liter ended in stillbirth;
the highest SCr value in pregnancies that ended successfully was
0.22 mmollliter. The live birth rate in patients with impaired renal
function tended to be higher in the recent decade (12 of 14
fetuses, or 86%) than in the preceding period (7 of 11 fetuses, or
64%).
The major risk factors of adverse fetal outcome were identified
as hypertension defined by MAP > 105 mm Hg (OR = 10, 95%
CI, 1.2 to 83.1; P = 0.04) and proteinuria> 1.5 g/day (OR = 16,
95% CI, 1.7 to 148; P = 0.02) whereas serum creatinine level was
not significant. After adjustment on Sr and proteinuria, only
MAP remained independently significant in a logistic regression
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Table 4. Fetal outcome in patients with impaired renal function at conception and prospective coordinated care
Gestation(s) Status at conception
Issue of gestation [birthweight, gJPatient order date (age) Sr p.mol/liter BP mm/Hg Proteinuria g/day Hb g/dl
1 GI 3/75 (24) 159 130/75 1.5 12.1 PD 36w (CS), alive [2350]
G2 9/78 (27) 212 145/90* 1.9 10.6 PD 34w (CS), alive [18001
2 G6 7/75 (30) 270 140/85 0.9 10.4 PD 30w, stillborn
3 G2 12/77 (24) 133 140/90 2.0 13.3 PD 32w, stillborn
G3 3/80 (27) 168 150/95 3.2 12.8 PD 27w, stillborn
4 Gi 6/79 (25) 122 100/65 0.2 13.1 PD 36w, alive [2600]
G2 7/84 (30) 141 110/70 0.4 12.2 TD 38w, alive [3050]
5 GI 11/85 (25) 112 140/85* 0.1 13.5 PD 31w (CS), alive [1200]
G2 5/89 (29) 118 135/85* 0.2 12.8 PD 36w (CS), alive [18801
6 Gi 10/80 (22) 144 130/80 0.8 12.5 PD 36w, alive [2200]
G2 8/82 (24) 168 150/85* 1.2 11.6 TD 37w, alive [2300]
7 Gi 6/81 (27) 159 135/90* 1.6 12.9 TD 38w, alive [3150]
8 Gi 1/82 (23) 490 140/90 2.6 9.9 SAb (14w)
9 Gi 4/85 (23) 140 140/80* 0.4 12.8 PD 28w (CS), stillborn
G2 10/87 (25) 142 130/80* 0.5 12.4 PD 33w (CS), alive [2250]
10 Gi 8/85 (25) 190 130/90 1.2 13.4 PD 30w (CS), alive [12001
G2 2/92 (32) 335 145/90* 2.0 11.7 SAb (14w)
11 G2 12/85 (26) 132 120/70 0.1 14.1 TD 39w, alive [30501
12 Gi 1/88 (26) 169 120/80* 1.0 12.4 PD 36w, alive [21701
G2 12/89 (28) 202 120/70* 1.5 12.1 TD 38w, alive [2450]
13 G4 6/88 (28) 122 130/80 0.1 14.2 TD 37w, alive [3020]
14 G2 4/89 (24) 212 120/70 0.8 11.8 PD 34w (CS), alive [2310]
15 Gi 4/93 (27) 228 120/80* 0.3 11.8 TD 37w, alive [2210]
16 G1(tw) 7/93 (24) 124 115/65 0.1 10.8 PD 25w (CS), alive [980, 960]
Abbreviations are: Gi, G2, etc, 1st, 2nd gestation, etc.; tw, twin pregnancy; TD, term delivery; PD, premature delivery; CS, cesarean section; SAb,
spontaneous abortion; Sr, serum creatinine; BP, blood pressure; Hb, blood hemoglobin level. The asterix after blood pressure indicates current
antihypertensive therapy at the time of conception.
model (P < 0.01). Of note, there was no correlation between the
degree of renal dysfunction assessed by Sc and blood pressure
level, although the incidence of hypertension was higher in
patients with impaired renal function than in those with preserved
renal function (80% vs. 3%, P < 0.0001).
Antenatal ultrasonography detected mild kidney pelvic dilation
in three fetuses. In one, subsequent micturating cystography
identified vesicoureteral refiux.
Influence of pregnancy on maternal renal disease
A physiological decrease in Sr was observed during the first
two trimesters of pregnancy in all patients whose Sr was < 0.11
mmol/liter at conception; a moderate, reversible increase in Sr
occurred at the end of pregnancy in four patients with borderline
renal dysfunction (Sr 0.093 to 0.108 mmol/liter at conception),
but no irreversible deterioration of renal function was observed in
any patient. Among patients whose renal function was impaired at
conception, a modest decline in SCr was observed in the first
trimesters of gestation in 19 pregnancies started with a S. level 
0.20 mmol/liter, with Sr declining from 145 22 to 129 24
smol/liter (a 11% decrease on the average), but in none of 7
pregnancies started with SCr > 0.20 mmol/liter at conception
where Sr progressed from 275 106 to 296 130 j.tmol/liter.
However, at end of gestation an increase in S. above the
preconception level was observed in all cases, which reversed
partially in all patients except four who subsequently experienced
an accelerated deterioration of renal function.
In the long-term, among the 137 women whose renal function
was normal before and during all pregnancies, 9 later developed
end-stage renal failure (ESRF) at a mean age of 45.9 9 years
(range 30 to 59). Similarly, 6 of the 31 women with reflux
nephropathy who had preserved renal function at childbearing
age and who never conceived, developed ESRF at a comparable
mean age of 45 15 years (range 33 to 61). By contrast, 11 of the
21 women whose renal function was already impaired at concep-
tion did reach ESRF at a mean age of 30.3 4.2 years (range 23
to 35), but there was no control group of patients with similar
degree of renal dysfunction in the third decade who did not
conceive.
Of the 21 patients with impaired renal function, 17 had a slow
course following their last pregnancy, with a mean rate of decline
in creatinine clearance of 0.33 0.11 ml/min/1.73 m2 per month
(range 0.10 to 0.53), which did not differ from the rate of 0.31
0.13 ml/min/1.73 m2 per month (range 0.12 to 0.45) previously
observed. By contrast, in the four patients who experienced an
accelerated deterioration, the rate of decline in creatinine clear-
ance ranged from a mean value of 0.87 to 0.11 ml/min/1.73 m2 per
month (range 0.67 to 1.03) as compared to a previous rate of 0.26
0.06 ml/min/1.73 m2 per month (range 0.17 to 0.32; P = 0.056).
All of the latter four patients were hypertensive; their Sr values
at conception ranged from 0.17 to 0.49 mmol/liter and their
protein excretion ranged from 0.8 to 2.6 g/24 hours. The only
significant difference between these patients and the other 17 who
had an unaffected course was a higher level and a lower
creatinine clearance at conception. Preconception levels of both
proteinuria and MAP tended to be higher in the former than in
the latter, but differences were not significant (Table 5).
Discussion
This large series of patients evaluating the outcome and com-
plications of pregnancy in women with refiux nephropathy clearly
highlights the benefit of current advances in obstetrical and
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Table 5. Preconception characteristics (mean SD) of 21 patients with
impaired renal function, according to the rate of decline in renal
function after beginning of the last pregnancy
Accelerated rate
(N = 4)
Stable rate
(N = 17) Pvalue
Scr mmol/liter 285 142 173 63 0.05
Ccr mi/mm 22.4 8.1 40.4 13.0 0.02
Proteinuriag/day 1.37 0.83 0.99 1.01 0.33
MAP mm Hg 120 9 109 15 0.54
neonatal care, as well as the crucial importance of a closely
coordinated care between obstetrician and nephrologist in pa-
tients with risk factors such as hypertension and/or impaired renal
function.
Overall fetal outcome in pregnant women with reflux nephrop-
athy has been long reported to be essentially good. In our initial
study the fetal death rate of 14% observed in 137 pregnancies in
53 patients with reflux nephropathy was significantly lower than
that of 25% observed in 240 pregnancies in patients with primary
glomerular diseases recorded during the same period [10]. Arze et
al reported an overall fetal death rate of 18% in 173 pregnancies,
in 79 women with refiux neophropathy [7]. The recently updated
study of the Melbourne group reports on 345 pregnancies in 137
women with reflux nephropathy [9]. The overall fetal loss rate
(excluding therapeutic abortions but considering first-trimester
spontaneous abortions) was 10.2%, a value very close to our
present findings. Their relatively high proportion of preterm
deliveries (22%) was also similar to what we observed (19.8% of
live births).
Our experience stresses the beneficial effect of recent progress
in obstetrics and neonatology, as evidenced by the fact that the
fetal death rate tended to decrease from 12.6% in pregnancies
that took place from 1965 to 1984 to 8.4% in those that occurred
in the past decade. This better result, which was especially
apparent in patients with risk factors such as hypertension and/or
impaired renal function, presumably reflects a lower perinatal
mortality rate in prematurely delivered infants because it was
observed despite the notably increased proportion of pre-term
delivered infants in the recent years, in parallel with the growing
number of patients with impaired renal function and/or hyperten-
sion who have been referred to our nephrology unit in the past
decade. Of note, an overrepresentation of patients with high-risk
pregnancies is likely to have occurred in our study population,
especially in view of the fact that a proportion of patients were
referred after an obstetrical complication.
Our study provides insights as to the factors affecting fetal
prognosis. Among complications that occurred in pregnancy in
women with reflux nephropathy, all of which were expected to
affect fetal outcome, UTI was the most frequent, occurring in 84
pregnancies (24%). However, although responsible for significant
maternal maternal morbidity, symptomatic UTI had a deleterious
effect on fetal outcome in a very limited number of cases, due to
the careful urinary screening and prompt treatment of UT! during
pregnancy in these patients. Acute pyelonephritic episodes during
pregnancy occurred mainly in patients who had previously expe-
rienced similar episodes, especially after becoming sexually active.
Upper UT! was infrequent in women with known impairment of
renal function, probably due to the particularly close surveillance
of such patients, as already observed by El Khatib et al [8, 9].
Interestingly, recurrence of upper UTI in pregnancy was observed
in only 3 of the 21 patients who underwent surgical correction of
vesicoureteral reflux prior to becoming pregnant, and in all three
cases ureteral reimplantation had been performed in infancy; no
recurrence of pyelonephritis occurred during pregnancy in women
who underwent correction at the adult age. Most of the acute
pyelonephritic episodes occurred in patients in whom vesicoure-
teral reflux was still present at the time of conception. Similarly,
Austenfeld and Snow observed recurrence of pyelonephritis dur-
ing pregnancy in a minority (5 of 30) of women who had
undergone surgical correction of primary vesicoureteral reflux in
infancy [16], and El Khatib et a! observed a threefold higher
incidence of ascending renal infection in women with persistent
vesicoureteral reflux [9]. Therefore, it may be advisable to recom-
mend prophylactic ureterovesical reimplantation in women with
persistent vesicoureteral reflux, at least in those who experienced
recurrent pyelonephritic episodes in their adult life. In any case,
because several recent reports mention a high risk of recurrence
of UT! [17—19] in pregnancy in women who underwent childhood
ureterovesical reimplantation, reinforced screening and early
treatment of any UTI is recommended to all patients having a
history, or persistent evidence, of vesicoureteral reflux.
The deleterious influence of hypertension and of renal failure
appears of much more consequence to fetal prognosis. When
pre-existent to conception, hypertension was associated with a
strikingly increased incidence of preeclampsia and the relative risk
of fetal loss was nearly five times higher than in normotensive
patients. However, when adequately controlled by antihyperten-
sive therapy from the time of conception, hypertension was not
associated with an increased fetal loss, but preeclampsia often
occurred, preterm delivery was frequent and most neonates were
of low birthweight and required specialized care.
The presence of significantly impaired renal function at con-
ception was the major risk factor for a complicated course of
pregnancy, inasmuch as hypertension was most often concomitant
to renal failure. In this situation, overall fetal death was nearly
37% in our patients, in contrast with a fetal death rate not
exceeding 8% in patients with preserved renal function, El Khatib
et al reported a fetal loss rate of 18% in 52 pregnancies in women
with reflux nephropathy and SCr> 0.11 mmol/liter at conception,
compared to a fetal loss of 8% among 239 pregnancies in patients
with preserved renal function [9]. Included in their series were six
patients with refiux nephropathy having a Sr concentration in
excess of 0.22 mmol/liter at conception or early in pregnancy
together with severe hypertension in whom the perinatal fetal
death rate was 33% [20]. An increased fetal loss rate was also
reported in women with various types of renal disease (both
glomerular and non-glomerular) and impaired renal function at
conception [21—23], Of note, about one quarter of our patients
had been referred following an obstetrical complication and
therefore did not benefit a prospective coordinated care; in this
subset fetal outcome was especially poor. By contrast, fetal
outcome was clearly more favorable in patients having an estab-
lished diagnosis prior to becoming pregnant, and in whom preg-
nancy was managed under prospective coordinated nephrologic
and obstetrical care. Planned pregnancy, optimal blood pressure
control prior to conception, and intensified joint obstetrical and
nephrological care throughout gestation therefore appear as key
factors for an optimal fetal outcome.
A critical problem is to define the level of renal impairment
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compatible with a reasonable chance of favorable fetal outcome.
Our present experience, in agreement with a recent study [23]
demonstrates that a successful pregnancy is often possible in
women with Sr up to 0.22 mmol/liter at conception. When the
Scr value exceeds this threshold (roughly corresponding to a
creatinine clearance of 30 mI/mm/I .73 m2), the risk of intrauterine
fetal loss, as well as of premature delivery and of very low
birthweight markedly increases. However, in the recent years,
several reports of successful pregnancies in patients with reflux
nephropathy and advanced renal failure occasionally appeared
[24, 25]. In these patients, Sr was higher than 0.30 mmol/liter,
and dialysis treatment was needed during gestation and usually
had to be pursued following delivery because of irreversible
deterioration of renal failure. In none of our patients was dialysis
started in pregnancy.
Infants born to mothers with vesicoureteral refiux may be
affected by the same disease [19]. Therefore, antenatal screening
for urinary tract abnormalities by fetal ultrasonography in the
third trimester of pregnancy should be recommended in women
with reflux nephropathy [26].
Our present study demonstrates the lack of deleterious effects
of pregnancy on maternal renal disease when renal function is
normal prior to conception, as already shown in patients with
primary glomerulonephritis [27]. In this situation, the physiolog-
ical decrease in Sr in the first trimesters of gestation was
consistently observed. There was no deterioration in renal func-
tion in late pregnancy nor postpartum, and the long-term course
of renal function was not affected by pregnancy.
A different pattern was observed in patients whose renal
function was already impaired before conceiving. A decline in Sr
in the first trimesters of gestation was observed only in our
patients whose S concentration at conception was less than 0.20
mmol/liter. This decrease was to a lesser extent than in patients
with preserved renal function, whereas no transient decline was
observed early in gestation in patients whose Sr was above 0.20
mmol/liter. A similar finding was reported by Cunningham et al in
patients with mixed types of renal disease [23]. Such a transient
decline in the first trimesters of gestation was not predictive of
uncomplicated subsequent course, however, as SCr increased in
late gestation in virtually all patients with impaired renal function,
irrespective of whether or not a transient decline had occurred
early in gestation.
The most important concern is whether or not pregnancy may
induce a irreversible worsening of renal function in the long-term
in such patients. In our present series, an indisputable accelerated
rate of decline in creatinine clearance, when compared to male
patients or to women who did not conceive [28], was observed in
only four patients. All had severe hypertension and heavy pro-
teinuria and three had 5Cr in excess of 0.21 mmol/liter and
creatinine clearance below 25 ml/min. An abnormally rapid rate
of decline of renal function was observed by Becker et al in six
hypertensive patients with reflux nephropathy whose Sr was in
the range of 0.22 to 0.4 mmol/liter at conception or early in
pregnancy, despite an adequate control of hypertension [20]. Such
an accelerated course has also been reported in about one third of
patients with impaired renal function due to other types of renal
disease, especially in glomerular diseases [21—231. However, such
an accelerated deterioration is perhaps less frequent than previ-
ously thought, as it was observed in only 20% of our patients, as
also reported by others [23]. The lack of any substantial reversal
in the Sr level at end of pregnancy was a frequent finding in those
patients who subsequently developed irreversible worsening of
renal failure, whereas patients who exhibited such a postpartum
reversal in Sr usually had a slow course.
The potential risk of accelerated deterioration of renal function
has to be taken in consideration for preconception counselling.
Women with reflux nephropathy and impaired renal function
should be encouraged to conceive as long as their renal function
is preserved or moderately impaired, that is, before S, has
reached 0.22 mmol/liter. Patients whose Sr is in excess of this
level, especially if heavy proteinuria and/or hypertension is also
present, should be clearly advised of the risks of both unsuccessful
pregnancy and irreversible deterioration of renal function. Accep-
tance or refusal of such risks largely depends on the decision of
the patient and spouse after imparting the full information on the
predictable outcomes and hazards of pregnancy.
In conclusion, pregnancy was essentially successful and un-
eventful in women with refiux nephropathy having normal or
near-normal renal function and well-controlled blood pressure,
UTI being responsible for frequent morbidity but few fetal
mortalities. Patients with hypertension and/or impaired renal
function were at increased risk of preeclampsia, prematurity, fetal
growth retardation and perinatal death, as well as of accelerated
deterioration of maternal renal disease. However, efficient control
of blood pressure and reinforced coordinated nephrologic and
obstetrical care markedly improved fetal outcome, and therefore
appear as the prerequisites for a successful pregnancy, especially
in women with hypertension and/or impaired renal function.
Reprint requests to Paul Jungers, M.D., Department of Nephrology, Necker
Hospital, 149 rue de Sèvres, 75015 Paris, France.
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